"10.1371_journal.pntd.0004297","plos neglected tropical diseases","2015-12-23T00:00:00Z","Elisangela Oliveira Freitas; Dirlei Nico; Marcus Vinícius Alves-Silva; Alexandre Morrot; Keith Clinch; Gary B Evans; Peter C Tyler; Vern L Schramm; Clarisa B Palatnik-de-Sousa","Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil; Department of Biochemistry, Albert Einstein College of Medicine, Yeshiva University, New York, New York, United States; Departamento de Imunologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil; The Ferrier Research Institute, Victoria University of Wellington, Wellington, New Zealand","Conceived and designed the experiments: CBPdS EOF DN. Performed the experiments: EOF CBPdS DN. Analyzed the data: EOF CBPdS DN MVAS AM. Contributed reagents/materials/analysis tools: KC GBE PCT VLS AM. Wrote the paper: CBPdS VLS GBE.","The chemical synthesis and uses of the immucillins are disclosed in several U.S. Patents under the general title Inhibitors of nucleoside metabolism. Authors Keith Clinch, Gary B. Evans, Peter C. Tyler and Vern L. Schramm are named in this patent family. The patents are owned by the Albert Einstein College of Medicine and VicLink of the University of Victoria, Wellington, New Zealand. The owners have licensed certain immucillins to the biotechnology industry for development in human use. The existence of these license agreements does not alter the authors adherence to all policies on sharing data and materials.","2015","12","Elisangela Oliveira Freitas","EOF",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
